Introducing the New K Dollar App with Enhanced Rewards and Exclusive Member Benefits
In Partnership with Visa to bring Rewarding Tram Rides #KDollar #Visa #Tram #KDollarApp #KDollarProgram #VisaInstantEarn HONG KONG, May 31, 2024 /PRNewswire/ — New World Development and Chow Tai Fook have jointly introduced the unified rewards program “K Dollar Program” (K Dolla
Denave unveils next-generation AI-powered revenue acceleration solutions
Extensive revenue development solutions will empower GTM Teams to drive scale & productivity with AI, automation, and deep buyer intelligence NOIDA, India, May 31, 2024 /PRNewswire/ — Denave, a leading revenue acceleration solution provider, today unveiled their human-enabled, Generative A
Bruhat Soma declared champion of the 2024 Scripps National Spelling Bee, sets new spell-off record
CINCINNATI, May 30, 2024 /PRNewswire/ — Bruhat (BROO-haht SOH-muh) Soma, a 12-year-old speller from Tampa, Florida, is the champion of the 2024 Scripps National Spelling Bee after winning the competition’s second spell-off to date. Soma correctly spelled 29 out of 30 words attempted to e
FutureBridge set to engage with industry leaders at 2024 ASCO® Annual Meeting and BIO 2024 International Conference
UTRECHT, Netherlands, May 30, 2024 /PRNewswire/ — FutureBridge, a leading techno-commercial consulting and advisory company focussing on R&D, innovation, strategy, scientific evidence, markets, reimbursement and regulatory aspects, is set to engage with industry leaders at two prestigious
FutureBridge set to engage with industry leaders at 2024 ASCO® Annual Meeting and BIO 2024 International Conference
UTRECHT, Netherlands, May 30, 2024 /PRNewswire/ — FutureBridge, a leading techno-commercial consulting and advisory company focussing on R&D, innovation, strategy, scientific evidence, markets, reimbursement and regulatory aspects, is set to engage with industry leaders at two prestigious
U.S. FDA ACKNOWLEDGES ASTELLAS’ RESUBMISSION OF BIOLOGICS LICENSE APPLICATION FOR ZOLBETUXIMAB AND SETS NEW ACTION DATE
If approved, the investigational therapy would offer a new treatment option for patients with advanced gastric and gastroesophageal junction cancers as the first and only CLDN18.2-targeted therapy in the U.S. TOKYO, May 30, 2024 /PRNewswire/ — Astellas Pharma Inc. (TSE: 4503, President and CEO
Tencent Ranks #1 across Asia Pacific by Revenue in the 2023 Gartner® Market Share Report for “Communications Platform as a Service”
HONG KONG, May 31, 2024 /PRNewswire/ — Tencent Cloud, the cloud business of global technology company Tencent, today announced its leading position in the Communications Platform as a Service (CPaaS) Market across the Asia-Pacific region and China. According to the Gartner research titled Mar
MediaTek to Unveil Products for Chromebooks, Smart TVs and Displays at COMPUTEX 2024, Highlighting Demonstrations in AI Processing
Vice Chairman and CEO Dr. Rick Tsai to share the company’s vision for ubiquitous AI at COMPUTEX 2024 HSINCHU, May 30, 2024 /PRNewswire/ — At COMPUTEX 2024, MediaTek will showcase new products and technology demonstrations, featuring highlights in AI, Smart TVs, Chromebooks, IoT and more
TSX Venture Exchange Stock Maintenance Bulletins
VANCOUVER, BC, May 30, 2024 /CNW/ – TSX VENTURE COMPANIES BULLETIN V2024-1627 CLOUDMD SOFTWARE & SERVICES INC. (“DOC”)BULLETIN TYPE: Reinstated for TradingBULLETIN DATE: May 30, 2024TSX Venture Tier 1 Company Further to the TSX Venture Exchange Bulletin dated May 8, 2024,
Record numbers expected at CPHI & PMEC China 2024 as Asian markets boom
Domestic and international markets in Asia surging as CPHI & PMEC China welcomes 60,000 attendees and 3500 exhibitors SHANGHAI and AMSTERDAM, May 30, 2024 /PRNewswire/ — CPHI & PMEC China (June 19-21st) returns to the Shanghai New International Expo Center amid soaring demand across
